Uncategorised - European Medical Journal

Clinical Efficacy and Outcomes of Remibrutinib (LOU064) in Patients with Chronic Spontaneous Urticaria Inadequately Controlled with H1-Antihistamines: Findings from a Phase IIb Study

As part of the 31st European Academy of Dermatology and Venereology (EADV) Annual Congress held in Milan, Italy, and online, 7th–10th September 2022, five poster presentations outlined results from the Phase IIb study of remibrutinib (LOU064) in patients with chronic spontaneous urticaria inadequately controlled with H1-antihistamines.

Difficult-to-Treat: Treating Symptoms Not Numbers

Nebojsa Skrepnik joins Jonathan Sackier on this episode of the EMJ Podcast to discuss opening a clinical research centre and platelet-rich plasma treatments.

High-Dose Vitamin D Beneficial in Patients with Cystic Fibrosis

High-dose vitamin D has been shown to be successful in increasing vitamin D levels in patients with cystic fibrosis and vitamin D deficiency.

Tool Accurately Detects Risk of Asthma in Young Children

Researchers have developed a tool allowing for the detection of asthma risk in children as young as 2 years old…

EMJ

Infographic: Improving Outcomes in Haemodialysis: A New Look at an Old Issue

This infographic explores a contemporary strategy to decrease the risk of cardiovascular disease and mortality associated with end-stage kidney disease (ESKD).

Renal Disease Risk: Direct Oral Anticoagulants Versus Vitamin K Antagonists

New research shows that using DOAC for the treatment of atrial fibrillation could reduce the risk of CKD progression.

Does Ethnicity Impact Hospitalisation Rates in Patients with Advanced Kidney Disease?

Ethnicity could play a role in hospitalisation outcomes for patients with advanced kidney disease. Read now to find out more.

Optimising Antimicrobial Stewardship to Tackle Clostridioides difficile Infection and Improve Patient Outcomes

Clostridioides difficile, formerly known as Clostridium difficile, is a Gram-positive spore-forming and toxin-producing bacterium that causes diarrhoea in vulnerable patient groups. It is a common hospital-acquired infection but also occurs in the community.

Precision Medicine in Prostate Cancer – Interview with Henrik Grönberg

Focusing on the topic of precision medicine in prostate cancer, this podcast offers valuable insights into the impact that its widespread…

New Frontiers in Chronic Obstructive Pulmonary Disease: Where Are We Heading?

All human diseases, including COPD, are the end result of gene–environment interactions.1 However, this conventional model is being modified. COVID-19 demonstrated that mortality is higher in older versus younger individuals. The viral and environmental exposures were the same, but the obvious difference was age.